Level B· Emerging Clinical Evidence

Efficacy of stromal vascular fraction in the treatment of scars: A systematic review and meta-analysis

Qiu K., Gan W., Chen X.

Pooled four studies with 145 patients (64 receiving SVF): significant benefit for vascularity, itching, POSAS and scar thickness.

Study type
Meta-analysis
Journal
Skin Research and Technology (2024)
Country
China
Sample size
145
Follow-up
Varied across included studies
PMID
39086176
DOI
10.1111/srt.13881

What was studied

Effects of SVF across multiple scar characteristics.

Methods

  • Searched PubMed, Embase, Cochrane and Web of Science.
  • Outcomes included vascularity, pigmentation, thickness, pliability, surface area, pain and itching.

Key findings

  • Significant improvement in vascularity (p = 0.04), itching (p = 0.002), POSAS (p = 0.001) and thickness (p < 0.001).
  • No significant difference for colour, pigmentation, surface area, pain or pliability.

Limitations

  • Only four studies with a small pooled sample.
  • Scar types and protocols differed.

What this study does not prove

  • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • Limited follow-up cannot indicate long-term outcomes.

Clinical interpretation

Positive but thin evidence — informative for decisions, not conclusive.

Evidence level: Emerging Clinical Evidence

View original source